Evaluation of V-Gel in Vaginitis and Cervicitis

Thirty five females diagnosed with vaginitis, clinically and microbiologically, were enrolled in the study to evaluate the efficacy of V-Gel. Patients were assessed subjectively for symptoms of vaginal discharge, pruritus, soreness of vulva, inflammation, foul odour and scratch marks. Vaginal discharge was subjected to microbiological diagnosis. The patients were advised to apply V-Gel with an applicator once daily, at night, for two weeks. At the end of two weeks, a significant number of patients showed evidence of clinical relief from the 7 th day onwards. Thirty patients showed inhibition of inflammation of vagina, cervix, vulva and disappearance of scratch marks. Twenty eight patients showed a reduction in foul odour of the discharge, 25 showed significant reduction of vaginal discharge, 18 showed relief in soreness and 16 showed relief from pruritus and itching. The results were optimum at second week where 14 females showed eradication of Trichomonas vaginalis, 15 showed eradication of Candida, 5 showed eradication of Gardnerella vaginalis and one patient showed eradication of nonspecific cocci. Thus, V-Gel significantly produced symptomatic relief and microbiological eradication in patients with vaginitis. Various constituents of V-Gel have anti-inflammatory and antimicrobial properties reported to be useful in the treatment of Leucorrhoea. Multiple components of V-Gel have produced synergistic effects with each other as seen from these results.